Claudine 18.2 : nouvelle cible thérapeutique dans les cancers digestifs

Q: How does OCRA curate its research paper database?

OCRA indexes peer-reviewed papers from PubMed and CrossRef, enriched with MeSH terms, author profiles, and citation metrics. Papers are categorized by cancer type, research method, and clinical relevance.

Q: Can I search papers by MeSH term or author?

Yes. Use the search bar to filter papers by MeSH term, author name, journal, keyword, or cancer type. Each paper includes linked MeSH terms and author profiles for further exploration.

Q: How current is the paper database?

The database is updated regularly through automated ingestion from PubMed and CrossRef. Most papers appear within days of their PubMed indexing date.

doi:10.1016/j.bulcan.2024.10.006

Claudine 18.2 : nouvelle cible thérapeutique dans les cancers digestifs

Laure Blondet & Thomas Samaille et al. · 2024-11-07

1Citations

Links

DOI PubMed

Journal

Bulletin du Cancer

TL;DR

The pathophysiology underlying the targeting of claudin 18.2 is presented, state of the art results of anti-claudin 18.2 therapies are summarized and future challenges for the management of patients with claudin 18.2 positive gastric and gastro-oesophageal junction adenocarcinoma are discussed.

AI-generated by Semantic Scholar

Authors

Laure Blondet, Baptiste Cervantes, Florence Renaud, Romain Cohen, Thierry André, Thomas Samaille